US › Healthcare

Envoy Medical Inc. (COCH)

US · Healthcare · Medical Devices

$7.15+0.70%

Last close · 2026-11-06

Latest quarter · ended 2026-09-30

Revenue

$66,000

Revenue YoY

+57.1%

Net profit

$-3.9M

EPS

$-0.50

EPS estimate

$-0.70

Net margin

-5,957.6%

EPS came in at -0.50 against a street estimate of -0.70 — a beat of 28.6%.

Key statistics

Market cap

$55.0M

Forward P/E

0.0

P/B

13.83

Book value

$0.48

EPS (TTM)

$-7.59

52-week high

$9.54

52-week low

$3.63

50-day MA

$6.82

200-day MA

$6.87

Beta

2.02

Analyst view

Analysts rate Envoy Medical Inc. a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $21.67.

Shareholding

Insiders

40.23%

Institutions

23.26%

Largest institutional holders

Fund	Stake
Nantahala Capital Management, LLC	19.77%
Bleichroeder LP	8.08%
Vanguard Capital Management, LLC	1.14%
Geode Capital Management, LLC	0.70%
The Colony Group LLC	0.55%
Vanguard Fiduciary Trust Co	0.38%
UBS Group AG	0.25%
Arcus Capital Partners LLC	0.24%

Corporate actions

Action	Detail	Date
Split	1 : 10 effective Oct 26, 2026	2026-10-26

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Envoy Medical Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.